FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921926156> ?p ?o ?g. }

• W2921926156 endingPage "S82" @default.
• W2921926156 startingPage "S74" @default.
• W2921926156 abstract "Abstract Background Typhoid fever illnesses are responsible for more than 100 000 deaths worldwide each year. In Bangladesh, typhoid fever is endemic, with incidence rates between 292–395 per 100 000 people annually. While considerable effort has been made to improve access to clean water and sanitation services in the country, there is still a significant annual typhoid burden, which particularly affects children. A typhoid conjugate vaccine (Vi-TCV) was recently prequalified by the World Health Organization and recommended for use, and offers the potential to greatly reduce the typhoid burden in Bangladesh. Methods This study is a double-blind, cluster-randomized, controlled trial of Vi-TCV in a geographically defined area in Dhaka, Bangladesh. At least 32 500 children from 9 months to &lt;16 years of age will be vaccinated and followed for 2 years to assess the effectiveness and safety of Vi-TCV in a real-world setting. All cluster residents will also be followed to measure the indirect effect of Vi-TCV in this community. Ethics and Dissemination This protocol has been approved by the International Centre for Diarrhoeal Disease Research, Bangladesh; a University of Oxford research review; and both ethical review committees. Informed written consent and assent will be obtained before enrollment. Vi-TCV has been shown to be safe and effective in previous, smaller-scale studies. The results of this study will be shared through a series of peer-reviewed journal articles. The findings will also be disseminated to the local government, stakeholders within the community, and the population within which the study was conducted. Conclusions This trial is the largest and only cluster-randomized control trial of Vi-TCV ever conducted, and will describe the effectiveness of Vi-TCV in an endemic population. The results of this trial may provide important evidence to support the introduction of TCVs in countries with a high burden of typhoid. Clinical Trials Registration ISRCTN11643110." @default.
• W2921926156 created "2019-03-22" @default.
• W2921926156 creator A5005586665 @default.
• W2921926156 creator A5021173085 @default.
• W2921926156 creator A5022660567 @default.
• W2921926156 creator A5031648902 @default.
• W2921926156 creator A5041318439 @default.
• W2921926156 creator A5044374911 @default.
• W2921926156 creator A5059494332 @default.
• W2921926156 creator A5059705866 @default.
• W2921926156 creator A5065914659 @default.
• W2921926156 creator A5082847955 @default.
• W2921926156 creator A5083943456 @default.
• W2921926156 creator A5084092871 @default.
• W2921926156 creator A5090498503 @default.
• W2921926156 date "2019-03-07" @default.
• W2921926156 modified "2023-10-16" @default.
• W2921926156 title "Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial" @default.
• W2921926156 cites W1803503496 @default.
• W2921926156 cites W1869075863 @default.
• W2921926156 cites W1969104565 @default.
• W2921926156 cites W1988422289 @default.
• W2921926156 cites W1996188732 @default.
• W2921926156 cites W2005242840 @default.
• W2921926156 cites W2023597927 @default.
• W2921926156 cites W2032990064 @default.
• W2921926156 cites W2049510865 @default.
• W2921926156 cites W2070969909 @default.
• W2921926156 cites W2078372129 @default.
• W2921926156 cites W2081698142 @default.
• W2921926156 cites W2102898060 @default.
• W2921926156 cites W2115048812 @default.
• W2921926156 cites W2136369541 @default.
• W2921926156 cites W2139462981 @default.
• W2921926156 cites W2340127586 @default.
• W2921926156 cites W2603477349 @default.
• W2921926156 cites W2732320847 @default.
• W2921926156 cites W2759562520 @default.
• W2921926156 cites W2782889149 @default.
• W2921926156 cites W4252052539 @default.
• W2921926156 cites W4299811586 @default.
• W2921926156 doi "https://doi.org/10.1093/cid/ciy1107" @default.
• W2921926156 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6405281" @default.
• W2921926156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30845333" @default.
• W2921926156 hasPublicationYear "2019" @default.
• W2921926156 type Work @default.
• W2921926156 sameAs 2921926156 @default.
• W2921926156 citedByCount "27" @default.
• W2921926156 countsByYear W29219261562019 @default.
• W2921926156 countsByYear W29219261562020 @default.
• W2921926156 countsByYear W29219261562021 @default.
• W2921926156 countsByYear W29219261562022 @default.
• W2921926156 countsByYear W29219261562023 @default.
• W2921926156 crossrefType "journal-article" @default.
• W2921926156 hasAuthorship W2921926156A5005586665 @default.
• W2921926156 hasAuthorship W2921926156A5021173085 @default.
• W2921926156 hasAuthorship W2921926156A5022660567 @default.
• W2921926156 hasAuthorship W2921926156A5031648902 @default.
• W2921926156 hasAuthorship W2921926156A5041318439 @default.
• W2921926156 hasAuthorship W2921926156A5044374911 @default.
• W2921926156 hasAuthorship W2921926156A5059494332 @default.
• W2921926156 hasAuthorship W2921926156A5059705866 @default.
• W2921926156 hasAuthorship W2921926156A5065914659 @default.
• W2921926156 hasAuthorship W2921926156A5082847955 @default.
• W2921926156 hasAuthorship W2921926156A5083943456 @default.
• W2921926156 hasAuthorship W2921926156A5084092871 @default.
• W2921926156 hasAuthorship W2921926156A5090498503 @default.
• W2921926156 hasBestOaLocation W29219261561 @default.
• W2921926156 hasConcept C138816342 @default.
• W2921926156 hasConcept C141071460 @default.
• W2921926156 hasConcept C142724271 @default.
• W2921926156 hasConcept C147483822 @default.
• W2921926156 hasConcept C159047783 @default.
• W2921926156 hasConcept C159110408 @default.
• W2921926156 hasConcept C168563851 @default.
• W2921926156 hasConcept C187212893 @default.
• W2921926156 hasConcept C203014093 @default.
• W2921926156 hasConcept C204787440 @default.
• W2921926156 hasConcept C2779583294 @default.
• W2921926156 hasConcept C2780151969 @default.
• W2921926156 hasConcept C2780801004 @default.
• W2921926156 hasConcept C2908647359 @default.
• W2921926156 hasConcept C512399662 @default.
• W2921926156 hasConcept C520601542 @default.
• W2921926156 hasConcept C68122502 @default.
• W2921926156 hasConcept C71924100 @default.
• W2921926156 hasConcept C99454951 @default.
• W2921926156 hasConceptScore W2921926156C138816342 @default.
• W2921926156 hasConceptScore W2921926156C141071460 @default.
• W2921926156 hasConceptScore W2921926156C142724271 @default.
• W2921926156 hasConceptScore W2921926156C147483822 @default.
• W2921926156 hasConceptScore W2921926156C159047783 @default.
• W2921926156 hasConceptScore W2921926156C159110408 @default.
• W2921926156 hasConceptScore W2921926156C168563851 @default.
• W2921926156 hasConceptScore W2921926156C187212893 @default.
• W2921926156 hasConceptScore W2921926156C203014093 @default.
• W2921926156 hasConceptScore W2921926156C204787440 @default.
• W2921926156 hasConceptScore W2921926156C2779583294 @default.

• next